Connecting to LinkedIn...



Top Biotech stocks for cancer cures from Cowen

16/05/2014 by


The conference season is starting to get into full swing, and for the top biotech stocks, that means an appearance at the American Society of Clinical Oncology yearly conference. Many of the top names present key data sets at their presentations, with some being brand new and some updating previously released results. With cancer expected to be the leading cause of death within the next 20 years, the top biotech companies are focusing on new treatments that may provide incredible breakthroughs.

The biotech team at Cowen has done a summary of data released or that will be released from some of the top biotech names in their coverage universe. Here is some of the commentary on stocks the firm rates as Outperform.

Amgen Inc, is the top blue chip name in the biotech world and at Cowen. A biotechnology pioneer since 1980, Amgen focuses on areas of high unmet medical need and leverages its biologics manufacturing expertise to strive for solutions that improve health outcomes and dramatically improve people’s lives. The company trades at a low 12.6 times forward earnings. The company will present for the first time results from its potentially pivotal Phase 2 trial of blinatumomab, which is a bi-specific T-cell engaging antibody that targets CD3+ T-cells to cancer cells expressing a tumor specific antigen. The biotech giant pays investors a solid 2.2% dividend. The Thomson/First Call price target for the stock is $132.64. Amgen closed Thursday at $110.29 a share.

This article has been extracted from, please click on this link to read the article in full

Montash is a multi-award winning, global IT recruitment firm. Specialising in permanent and contract positions across mid-senior appointments which cover a wide range of industry sectors and IT functions, including:

ERP, BI & Data, Information Security, IT Architecture & Strategy, Scientific Technologies, Demand IT and Business Engagement, Digital and E-commerce, Infrastructure and Service Delivery, Project and Programme Delivery.

With offices based in London, Montash has completed assignments in over 30 countries and has appointed technical professionals from board level to senior and mid-management in permanent and contract roles.

For more information please visit

comments powered by Disqus

Social Stream

Latest News


Humans remain largest security flaw in cloud ...

2016-10-21 14:00:00 +0100

With a vast number of companies moving some, if not all, of their operations to the cloud, security continues to be of major concern. Whilst there are numerous patches and firewalls to safeguard defences, it has been highlighted that the most difficult area to protect against is human interaction. This is the view of Jamie Woodruff, a penetration tester and ethical hacker. Woodruff’s views come after he was contracted to conduct a penetration test in or...


Offshore exploration providing boost for oil ...

2016-10-19 09:00:00 +0100

The oil and gas industry has had a notoriously challenging time of late, with the prices of oil plummeting and causing many firms to tighten their belts. However, offshore exploration is providing a much-needed bright spot for the sector, with an increasing number of governments becoming more accommodating. In the past week, it has been revealed that there are big changes afoot for Brazil’s petroleum laws. Shell has already begun to move on this opportu...